319 related articles for article (PubMed ID: 12364354)
1. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
[TBL] [Abstract][Full Text] [Related]
2. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL
Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645
[TBL] [Abstract][Full Text] [Related]
3. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.
Neves MF; Virdis A; Schiffrin EL
J Hypertens; 2003 Jan; 21(1):189-98. PubMed ID: 12544451
[TBL] [Abstract][Full Text] [Related]
4. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation.
Diep QN; Amiri F; Touyz RM; Cohn JS; Endemann D; Neves MF; Schiffrin EL
Hypertension; 2002 Dec; 40(6):866-71. PubMed ID: 12468571
[TBL] [Abstract][Full Text] [Related]
5. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice.
Virdis A; Neves MF; Amiri F; Touyz RM; Schiffrin EL
J Hypertens; 2004 Mar; 22(3):535-42. PubMed ID: 15076159
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
[TBL] [Abstract][Full Text] [Related]
7. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
[TBL] [Abstract][Full Text] [Related]
9. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation.
Wei Y; Whaley-Connell AT; Habibi J; Rehmer J; Rehmer N; Patel K; Hayden M; DeMarco V; Ferrario CM; Ibdah JA; Sowers JR
Hypertension; 2009 Feb; 53(2):158-65. PubMed ID: 19114643
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
12. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.
Lastra G; Whaley-Connell A; Manrique C; Habibi J; Gutweiler AA; Appesh L; Hayden MR; Wei Y; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E110-6. PubMed ID: 18445755
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
Luther JM; Gainer JV; Murphey LJ; Yu C; Vaughan DE; Morrow JD; Brown NJ
Hypertension; 2006 Dec; 48(6):1050-7. PubMed ID: 17043157
[TBL] [Abstract][Full Text] [Related]
14. Increased microparticle production and impaired microvascular endothelial function in aldosterone-salt-treated rats: protective effects of polyphenols.
López Andrés N; Tesse A; Regnault V; Louis H; Cattan V; Thornton SN; Labat C; Kakou A; Tual-Chalot S; Faure S; Challande P; Osborne-Pellegrin M; Martínez MC; Lacolley P; Andriantsitohaina R
PLoS One; 2012; 7(7):e39235. PubMed ID: 22808030
[TBL] [Abstract][Full Text] [Related]
15. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
[TBL] [Abstract][Full Text] [Related]
17. Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat.
Park YM; Lim BH; Touyz RM; Park JB
J Korean Med Sci; 2008 Dec; 23(6):1039-45. PubMed ID: 19119450
[TBL] [Abstract][Full Text] [Related]
18. Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension.
Zhou MS; Jaimes EA; Raij L
J Hypertens; 2005 Sep; 23(9):1737-43. PubMed ID: 16093920
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
[TBL] [Abstract][Full Text] [Related]
20. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
Diep QN; El Mabrouk M; Cohn JS; Endemann D; Amiri F; Virdis A; Neves MF; Schiffrin EL
Circulation; 2002 May; 105(19):2296-302. PubMed ID: 12010913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
